Related Experiment Videos
[Use of acetazolamide in external hydrocephalus in infants]
1Service de Pédiatrie A, Centre Robert Debré, CHU, Angers.
Insights
Acetazolamide effectively treated external hydrocephalus in four of five children. This safe medication is recommended for all patients with cerebrospinal fluid (CSF) resorption disorders.
Area of Science:
- Neurology
- Pediatrics
- Pharmacology
Context:
- External hydrocephalus (EH) is often considered benign, but its long-term prognosis lacks definitive evidence.
- Published data on EH prognosis is insufficient to confirm its typically benign nature.
Purpose:
- To evaluate the therapeutic effectiveness and tolerance of acetazolamide in children with external hydrocephalus.
- To assess acetazolamide's potential role in managing cerebrospinal fluid (CSF) resorption disorders.
Summary:
- Acetazolamide was administered to five children diagnosed with typical external hydrocephalus.
- Therapeutic effectiveness, indicated by head circumference measurements and other investigations, was observed in four out of the five patients.
- The study highlights acetazolamide's excellent tolerance and anatomical effectiveness in this small cohort.
Impact:
- The findings suggest acetazolamide is a well-tolerated and effective treatment option for external hydrocephalus.
- The study supports the broader use of acetazolamide in managing conditions involving CSF resorption disorders.
- Further research is warranted to definitively establish acetazolamide's ability to prevent adverse events associated with external hydrocephalus.
Abstract:
External hydrocephalus is believed to be benign but published cases do not clearly establish this prognosis. Five children with typical external hydrocephalus were given acetazolamide. Head circumference measurements or other investigations demonstrated therapeutic effectiveness in four of the five patients. Although this series is too small to establish that acetazolamide avoided external hydrocephalus-related adverse events, the drug's outstanding tolerance and anatomic effectiveness justify widespread use in all patients with CSF resorption disorders.